The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving ...

The European Commission (EC) has granted marketing authorisation to Leo Pharma ’s Anzupgo (delgocitinib) cream for treating ...

Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

Telix has paid an upfront cost of $230m to acquire 31 licenced radiopharmacies from RLS located across the US.

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...

UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.

Inovio Pharmaceuticals secures a patent for innovative nucleic acid molecules targeting Survivin-expressing tumors, paving the way for advanced cancer therapies and vaccines.

Discover Ono Pharmaceutical's groundbreaking patent for autophagy-inhibiting compounds, targeting various cancers with innovative MEK inhibitors like selumetinib.

Discover Lyell Immunopharma's groundbreaking patent for EGFR-derived polypeptides, enhancing cancer treatment through innovative nucleic acid technologies and engineered T cells.

Discover Zydus Lifesciences' patented stable oral liquid formulation of vigabatrin, designed for optimal efficacy and low impurities, ensuring patient-friendly medication.

Discover Aldeyra Therapeutics' new patent for I-1, a quinoline compound targeting inflammatory and respiratory diseases. Explore its formulations, dosages, and pharmacokinetics.